Sign in
4

Changes in Ownership

Starling Oncology, Inc. Filed Acc 0000935836-25-000416

Director sold 1,976,137 shares at $2.87 ($5,672,106)

  • Director acquired 1,867,605 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Hively Brad · Director

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2025-06-03 Exercise or conversion : show line 1 in the form +684,528 $0.85 $581,849 1,396,561 D
2025-06-03 Exercise or conversion : show line 2 in the form +105,320 $0.48 $50,659 1,501,881 D
2025-06-03 Exercise or conversion : show line 3 in the form +131,297 $1.87 $245,525 1,633,178 D
2025-06-03 Exercise or conversion : show line 4 in the form +946,460 $0.85 $804,491 2,579,638 D
2025-06-03 Sale : show line 5 in the form −1,867,605 $2.87 $5,360,587 712,033 D
2025-06-03 Sale : show line 6 in the form −108,532 $2.87 $311,519 603,501 D
Open-market sales · 1,976,137 sh · avg $2.87 · $5,672,106

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2025-06-03 Exercise or conversion : show line 7 in the form Non-Qualified Stock Option (right to buy) +684,528 0 D
2025-06-03 Exercise or conversion : show line 8 in the form Non-Qualified Stock Option (right to buy) +105,320 0 D
2025-06-03 Exercise or conversion : show line 9 in the form Non-Qualified Stock Option (right to buy) +131,297 0 D
2025-06-03 Exercise or conversion : show line 10 in the form Non-Qualified Stock Option (right to buy) +946,460 0 D
Loading xslF345X05/ownership.xml…